Copy the page URI to the clipboard
Kale, Dinar and Huzair, Farah
(2015).
URL: http://druid8.sit.aau.dk/acc_papers/s2roq4v7f5beej...
Abstract
This paper examines heterogeneity in the response of Indian firms to the emergence of a new disruptive market segment - biosimilars. Using the novel analytical tool of a technology- market capability matrix we show that path dependency and managerial vision are key drivers of heterogeneity in the reconfiguration processes and strategies employed by incumbent firms to compete in a new disruptive market. Analysis reveals that entry into international markets and accessing external sources of knowledge formed core elements of experimentation with strategy.
Viewing alternatives
Item Actions
Export
About
- Item ORO ID
- 43557
- Item Type
- Conference or Workshop Item
- Keywords
- biosimilars; India; pharmaceutical industry; dynamic capabilities; heterogeneity
- Academic Unit or School
-
Faculty of Arts and Social Sciences (FASS) > Social Sciences and Global Studies > Development
Faculty of Arts and Social Sciences (FASS) > Social Sciences and Global Studies
Faculty of Arts and Social Sciences (FASS)
Faculty of Science, Technology, Engineering and Mathematics (STEM) > Engineering and Innovation
Faculty of Science, Technology, Engineering and Mathematics (STEM) - Research Group
-
Innovation, Knowledge & Development research centre (IKD)
?? idii ??
Institute for Innovation Generation in the Life Sciences (Innogen) - Copyright Holders
- © 2015 The Authors
- Related URLs
- Depositing User
- Dinar Kale